Etanercept acts as a decoy receptor, binding to TNF-α to prevent interactions with TNF receptors on cell surfaces. This inhibits the downstream inflammatory cascade, which reduces keratinocyte hyperproliferation and inflammation in psoriasis [194]. Here, TNF is linked to psoriasis.